Emergent BioSolutions: I See Further Downside Ahead In This Value Trap
Emergent BioSolutions struggles with declining revenues, rising competition, and weak growth prospects. Read why I rate EBS ...
Purdue University7y
Strategy Sprints
About 30% of the time is spent focused on Pathfinder Projects and action steps. Emergent or agile strategy differs from strategic planning in fundamental respects. Emergent strategy combines ...
The Fulcrum on MSN7dOpinion
The Care and Feeding of a Superpower
The Department of Government Efficiency, DOGE, led by an unelected billionaire and supported by the Donald Trump ...
Harvard Business School4y
Managing the Strategy Development Process: Deliberate vs. Emergent Strategy
Christensen, Clayton M. "Managing the Strategy Development Process: Deliberate vs. Emergent Strategy." Harvard Business School Module Note 420-084, December 2019. (Revised November 2021.) ...
Nasdaq18d
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving ...
The Business Journals20d
Drug manufacturer to sell Baltimore plant for $36.5M
The sale is part of Emergent's cost-cutting strategy. Syngene will gain its first U.S. facility in Baltimore. One of Maryland’s largest biotechnology companies will sell its Bayview facility for ...